GenMont Biotech Inc (3164)

Currency in TWD
16.50
+0.20(+1.23%)
Closed·
Advertisement
3164 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.2516.50
52 wk Range
15.9020.75
Key Statistics
Bid/Ask
25.05 / 25.10
Prev. Close
20.2
Open
16.3
Day's Range
16.25-16.5
52 wk Range
15.9-20.75
Volume
35.57K
Average Volume (3m)
69.82K
1-Year Change
-18.5185%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3164 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

GenMont Biotech Inc News & Analysis

Show more

Earnings

Latest Release
08/05/2026
EPS / Forecast
0.05 / --
Revenue / Forecast
89.17M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.52%
Dividend Yield
3.96%
Industry Median 4.27%
Annualised payout
0.80
Paid annually
5-Years Growth
+2.71%
Growth Streak

Compare 3164 to Peers and Sector

Metrics to compare
3164
Peers
Sector
Relationship
P/E Ratio
31.6x−11.1x−0.3x
PEG Ratio
2.030.130.00
Price/Book
1.1x2.9x2.6x
Price / LTM Sales
3.6x62.0x3.0x
Upside (Analyst Target)
-0.0%56.7%
Fair Value Upside
Unlock−3.3%9.4%Unlock

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
102.31K0.12%1.69M
Other Institutional Investors
11.55M13.42%190.49M
Public Companies & Retail Investors
74.36M86.46%1.23B
Total
86.01M100.00%1.42B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Haide Asset Management Co., Ltd.8.30%7,140,000117,810
Yuzhan Investment Co., Ltd.5.12%4,405,00072,683

FAQ

What Is the GenMont Biotech (Taiwan: 3164) Share Price Today?

The GenMont Biotech stock price today is 16.50 TWD.

What Stock Exchange Does GenMont Biotech (3164) Trade On?

GenMont Biotech is listed and trades on the Taiwan Stock Exchange.

What Is the Ticker (Stock Symbol) for GenMont Biotech?

The stock symbol (also called a 'ticker') for GenMont Biotech is "3164."

Does GenMont Biotech Pay Dividends? What’s The Current 3164 Dividend Yield?

Yes, 3164 Pays Dividends to its Shareholders. The current GenMont Biotech dividend yield is 3.96%.

What Is the Current GenMont Biotech Market Capitalisation?

As of today, GenMont Biotech (Taiwan: 3164) market cap is 1.42B TWD.

What Is GenMont Biotech's (3164) Earnings Per Share (TTM)?

The GenMont Biotech EPS is currently 0.52 (Trailing Twelve Months).

Is 3164 a Buy or Sell From a Technical Analyst Perspective?

Based on today's GenMont Biotech moving averages and other technical indicators, the daily buy/sell signal for 3164 stock is Strong Buy.

How Many Times Has GenMont Biotech Stock Split?

GenMont Biotech has split 4 times. (See the 3164 stock split history page for full effective split date and price information.)

What is the current trading status of GenMont Biotech (Taiwan: 3164)?

As of 01/08/2026, GenMont Biotech (3164) is trading at a share price of 16.50 TWD, with a previous close of 20.20 TWD. The stock has fluctuated within a day range of 16.25 TWD to 16.50 TWD, while its 52-week range spans from 15.90 TWD to 20.75 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.